US approves first new Alzheimer’s drug in 20 years – BBC News
The initial brand-new treatment for Alzheimer’s illness for nearly two decades has actually been approved by regulatory authorities in the USA, paving the way for its use in the UK.
Aducanumab targets the underlying reason for Alzheimer’s, one of the most common type of dementia, instead than its symptoms.
Charities have actually invited the information of a new therapy for the condition.
Researchers are split over its potential impact due to the fact that of unpredictability over the test results.
Please subscribe HERE http://bit.ly/1rbfUog
#BBCNews
